Hjem › Fokal segmental glomerulosklerose › Texas › Houston
Fokal segmental glomerulosklerose kliniske forsøg i Houston, TX
5 studier for Fokal segmental glomerulosklerose søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
RekruttererFase 2
- Investigator Site #18, Houston
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
RekruttererFase 3
- Provecta Researh Network, Houston
- Provecta Research Path Forward Ventures, Humble · 17 mi væk
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RekruttererFase 2
- Prolato Clinical Research Center- Site Number : 8400016, Houston
Nephrotic Syndrome Study Network
RekruttererObservationsstudie
- Texas Children's Hospital - Baylor College of Medicine, Houston
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RekruttererFase 2
- Texas Children's Hospital, Houston
Fokal segmental glomerulosklerose forsøg i andre byer
- Philadelphia, PA9 studier
- Durham, NC8 studier
- New York City, NY7 studier
- Ann Arbor, MI6 studier
- Queens, NY6 studier
- Miami, FL6 studier
- Los Angeles, CA6 studier
- Atlanta, GA5 studier
- Cleveland, OH4 studier
- Chicago, IL4 studier
- Dallas, TX4 studier
- Kansas City, MO4 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.